Research programme: calcium channel antagonists - Ajinomoto
Alternative Names: AGS 1164; APJ 2708; APJ 2929Latest Information Update: 04 Nov 2017
At a glance
- Originator Ajinomoto
- Class Dihydropyridines
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Neuropathic pain
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Neuropathic-pain in Japan (PO)
- 09 Sep 2010 Preclinical development is ongoing in Japan
- 04 Sep 2008 Preclinical development is ongoing in Japan